Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

Market Cap	8.86B
Revenue (ttm)	1.01B +128.1%
Net Income	226.74M +67.6%
EPS	3.70 +68.0%
Shares Out	72.79M
PE Ratio	32.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	112,702
Average Volume	2,349,448
Open	117.00
Previous Close	121.77
Day's Range	115.69 - 117.00
52-Week Range	69.18 - 133.00
Beta	n/a
RSI	62.14
Earnings Date	May 29, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopi...

• Industry: Specialty Outpatient Facilities, Not Elsewhere Classified
• Founded: 2009
• Employees: 117
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GAUDIUMIVF

Financial Performance

In fiscal year 2025, NSE:GAUDIUMIVF's revenue was 707.24 million, an increase of 47.68% compared to the previous year's 478.90 million. Earnings were 191.27 million, an increase of 85.40%.